S408 • OFID 2019:6 (Suppl 2) • Poster Abstracts provides oversight for 6 Columbus NICUs, and Our objective was to evaluate the impact of the vancomycin reduction program, with secondary objectives including duration of therapy, recurrence of BSI within 14 days of completion of therapy, and mortality.
Background. Overuse of antibiotics in Respiratory Syncytial virus (RSV) bronchiolitis in children has been reported between 29-80%. Our antibiotic stewardship program (ASP) utilized a validated communication tool using TeamSTEPPS ® 2.0 principles to improve pharmacy-physician communication and improve audit-feedback technique (AFT).
Methods. We trained pharmacists and physicians in TeamSTEPPS ® 2.0 using simulation-based training. The key component of the training was: closed-loop communication and using a scripted pharmacy communication tool. The scripted pharmacy communication tool was modified from the "DESC" script used in TeamSTEPPS ® 2.0, which includes (1) Describing the situation, (2) Expressing concern, (3) providing Solutions, (4) stating Consequences and coming to an agreement. We incorporated this to improve the audit-feedback technique. We aimed to: (1) Reduce overall percentage of antibiotic (abx) use in RSV bronchiolitis by 25%, (2) reduce use of ceftriaxone, (3) reduce average antibiotic days of therapy (DOT).
Results. Our baseline data from 2017-18 RSV season showed a 42% (48/113) use of abx, of which 10% were deemed inappropriate. When compared with the 2018-2019 season, no differences were noted in patient demographics. The median length of stay between the two time periods was similar (2.9 days, IQR 1.9-4.8 days vs. 3.1 days, IQR 2.1-5.1 days, P = 0.17). More patients were admitted to the pediatric intensive care unit (PICU) in the 2018-2019 period: 35/96 (36.4%) as compared with 17/113 (15%) in the previous season. Although similar proportions of patients received abx (42% vs. 41%) in the two groups (Figure 1 ), average abx DOT, significantly decreased in the 2018-2019 period as compared with 2017-2018 ( Figure 2 ). There was also a decrease in the use of ceftriaxone during the 2018-2019 ( Figure 3 ). All physicians and pharmacists were satisfied with the communication technique and thought that it improved their interaction and understanding of the ASP process.
Conclusion. Though we did not reduce the overall abx use in RSV bronchiolitis, we did reduce the average abx DOT and use of ceftriaxone in our institution. The use of a validated communication tool to improve prospective AFT was crucial to the success of the ASP program.
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No reported disclosures. Friday, October 4, 2019: 12:15 PM Background. Early-life exposure to antibiotics is associated with childhood asthma. We previously reported that a dramatic drop in infant antibiotic use is correlated with a decline in asthma incidence in children in British Columbia (BC). This study aims to see whether antibiotic exposure predicts asthma at a fine geographic scale after adjustment for known covariates.
Antibiotic Use in Infants Predicts Asthma Rate in Children 1-4 years at Fine Geographic Scale
Methods. We used prescribing data from BC PharmaNet, a population-based database capturing all outpatient prescribing for BC population (n = 4.7 million). Prescribing rates for infants <1 year were calculated as prescriptions per 1000 population per year using age and sex-specified denominator estimates. Age-adjusted aggregate asthma incidence data for children 1-4 years were obtained from the BC Ministry of Health Chronic Disease Registry. The disease identification uses a standard case definition making using of diagnostic codes (ICD9-493 and ICD10-J45) in BC's universal hospital and physician billing databases and relevant asthma-specific drug data from BC PharmaNet. We modeled the association between antibiotic prescribing rate and asthma incidence in 91 Local Health Areas using multivariable Poisson regression employing a generalized linear mixed-effects model adjusting for covariates.
Results. Between 2000 and 2014, the annual asthma incidence (ages 1-4 years) fell 26% from 27.3 (95% CI: 26.5-28.0) to 20.2 (95% CI: 19.5-20.8) per 1000 population. For children aged 1-4 years in 2000, the average proportion of infants exposed to one or more courses of antibiotics fell from 66.9 to 32.1% over the same interval. Antibiotic was a significant predictor of asthma rate (IRR=1.24 per 10% absolute increase in antibiotic prescribing; 95% CI: 1.19-1.27). Other covariates that remained significant in the model included male sex (IRR=1.56; 95% CI: 1.53-1.58), and atmospheric particulate matter PM 2.5 (IRR=1.08 per interquartile increase; 95% CI: 1.06-1.10).
